ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284313.78584.ac
◽
2007
◽
Vol 2
(8)
◽
pp. S824
Author(s):
Andriani G. Charpidou
◽
Nikolaos Katirtzoglou
◽
Ioannis Gkiozos
◽
Eleni Karapanagiotou
◽
Anna Rigopoulou
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
Related Documents
Cited By
References
Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial
Lung Cancer
◽
10.1016/s0169-5002(98)90063-0
◽
1998
◽
Vol 21
◽
pp. S33
◽
Cited By ~ 1
Author(s):
V Georgoulias
◽
Ch Kourousis
◽
N Androulakis
◽
S Kakolyris
◽
MA Dimopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer
Clinical Lung Cancer
◽
10.1016/j.cllc.2011.08.004
◽
2012
◽
Vol 13
(2)
◽
pp. 129-135
◽
Cited By ~ 5
Author(s):
Athanasios G. Pallis
◽
Alexandra Voutsina
◽
Nikolaos Kentepozidis
◽
Stylianos Giassas
◽
Pavlos Papakotoulas
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
Download Full-text
P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.875
◽
2021
◽
Vol 16
(3)
◽
pp. S501
Author(s):
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Extensive Stage
Download Full-text
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial
Annals of Oncology
◽
10.1023/a:1008336931378
◽
2000
◽
Vol 11
(4)
◽
pp. 435-440
◽
Cited By ~ 115
Author(s):
C. Manegold
◽
U. Gatzemeier
◽
J. von Pawel
◽
R. Pirker
◽
R. Malayeri
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Multicenter Phase
◽
Pemetrexed Disodium
Download Full-text
Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7316
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
Author(s):
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Prolonged Infusion
Download Full-text
A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7263
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Author(s):
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
A Weekly Combination of Carboplatin and Irinotecan for Previously Untreated Extensive Disease Small-cell Lung Cancer, Results of a Minimum Follow-up of 3 Years: A Multi-center Phase II Trial JMTO LC02-02
Japanese Journal of Clinical Oncology
◽
10.1093/jjco/hys028
◽
2012
◽
Vol 42
(5)
◽
pp. 387-393
◽
Cited By ~ 4
Author(s):
K. Okishio
◽
T. Mio
◽
M. Kawahara
◽
H. Yoshioka
◽
K. Yanagihara
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial
Lung Cancer
◽
10.1016/s0169-5002(05)80950-x
◽
2005
◽
Vol 49
◽
pp. S236-S237
Author(s):
D. Binder
◽
H. Schweisfurth
◽
C. Grah
◽
C. Schäper
◽
B. Temmesfeld-Wollbrück
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
First Line
◽
First Line Treatment
Download Full-text
Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7316
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
Author(s):
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Prolonged Infusion
Download Full-text
A phase II trial of single-agent vinflunine as second-line treatment for advanced non-small cell lung cancer (An International Oncology Network Study, #I-05–009)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.19033
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 19033-19033
◽
Cited By ~ 1
Author(s):
M. Joppert
◽
M. Knapp
◽
S. R. Dakhil
◽
R. V. Boccia
◽
R. Steis
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Single Agent
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close